Komori
tripla (5136) · RiskRestated

Risk of Infectious Diseases Other Than COVID-19

First written in FY2022. 2 of 3 entries say "Restated". Latest entry: FY2025.

3entries
4years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2022 – FY20252023: 120232024: 020242025: 120252026: 1
Same theme, other companies
Impact on business performance and financial condition from unforeseen events such as natural disasters, terrorism, war and epidemicsA theme 29 companies write about · 29 as a headwind · 0 as a tailwind

The whole theme swung hardest in 2020: 15 of 22 companies on the "Worse" side.

10 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 29 companies compared. The sentences above are computed from all 29.
Full recordFilings, disclosures and news, newest first
  1. FY2025RestatedAnnual report

    「Travel demand was significantly affected by the spread of COVID-19 from 2020 onward, but infectious diseases other than COVID-19 may also spread in the future.」

    The possibility that infectious diseases other than COVID-19 could reduce travel demand, reservations and contracts continues to be disclosed.
  2. FY2024RestatedAnnual report

    「Because this risk cannot be completely eliminated, we recognize that it could materialize in the event of a sharp change in market conditions or other circumstances.」

    The possibility that infectious diseases other than COVID-19 could reduce accommodation demand, reservations and contracts continues to be disclosed.
  3. FY2022First statedAnnual report

    「The emergence or spread of a new infectious disease could reduce usage-based revenue linked to reservation volumes and operating revenue through slower acquisition of new contracts, facility closures and declines in the number of contracts, affecting our business and results.」

    The company cites SARS and MERS as examples and plans to apply the measures developed during the COVID-19 pandemic.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for tripla yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Risk of Infectious Diseases Other Than COVID-19 | tripla Co.,Ltd. (5136) | Komori